Kang Stem Biotech Co Ltd operates in the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Kang Stem Biotech Co Ltd with three other
companies in this sector in South Korea:
sales of 7.71 billion Korean Won [US$6.79 million]
of which 100%
was Life Engineering Research),
(7.70 billion Korean Won [US$6.78 million]
GL Pharm Tech Corp
(8.00 billion Korean Won [US$7.04 million]
of which 63%
was Finished Goods).
Kang Stem Biotech Co Ltd reported sales of 9.17 billion Korean Won (US$8.07 million)
December of 2018.
a very small
increase of 0.4%
versus 2017, when the company's sales were 9.13 billion Korean Won.
Sales of Cosmetics Business saw an increase
that was more than double the company's growth rate: sales were up
18.4% in 2018, from
4.41 billion Korean Won to 5.22 billion Korean Won.
Not all segments of Kang Stem Biotech Co Ltd experienced an increase in sales in 2018:
sales of Cells Medicine fell 58.3% to 409.28 million Korean Won.
Kang Stem Biotech Co Ltd also experienced decreases in sales in
Nonclinical Cro (down 5.5% to 3.53 billion Korean Won)